{{medical}}
{{Infobox drug
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 460023156
| drug_name         = 
| INN               = 
| type              = <!-- empty -->
| image = Cefixime.svg
| width             = 
| alt               = 
| caption           = 

<!-- Clinical data -->
| pronounce         = 
| tradename = Suprax等<ref name=genericnames>{{cite web|title=Cefixime—Drugs.com|url=https://www.drugs.com/international/cefixime.html|website=www.drugs.com|accessdate=2016-12-10|dead-url=no|archiveurl=https://web.archive.org/web/20160530044200/http://www.drugs.com/international/cefixime.html|archivedate=2016-05-30}}</ref><ref name="FDC—Products—Formulations">{{cite web |title=FDC—Products—Formulations |website=fdcindia.com |url=http://www.fdcindia.com/formulations.php |access-date=2018-05-02 |archive-date=2018-04-26 |archive-url=https://web.archive.org/web/20180426230350/http://www.fdcindia.com/formulations.php |dead-url=no }}</ref>
| Drugs.com = {{drugs.com|monograph|cefixime}}
| MedlinePlus = a690007
| licence_CA        = <!-- Health Canada may use generic or brand name (generic name preferred) -->
| licence_EU        = <!-- EMA uses INN (or special INN_EMA) -->
| DailyMedID        = Cefixime
| licence_US        = <!-- FDA may use generic or brand name (generic name preferred) -->
| pregnancy_AU      = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_AU_comment = 
| pregnancy_US      = B
| pregnancy_US_comment = <ref name="Drugs.com pregnancy">{{cite web | title=Cefixime (Suprax) Use During Pregnancy | website=Drugs.com | date=2019-03-29 | url=https://www.drugs.com/pregnancy/cefixime.html | access-date=2019-12-24 | archive-date=2016-12-20 | archive-url=https://web.archive.org/web/20161220224931/https://www.drugs.com/pregnancy/cefixime.html | dead-url=no }}</ref>
| pregnancy_category = 
| dependency_liability = 
| addiction_liability = 
| routes_of_administration = 口服給藥<ref name="Suprax FDA label">{{cite web | title=Suprax- cefixime tablet Suprax- cefixime capsule Suprax- cefixime tablet, chewable Suprax- cefixime powder, for suspension | website=DailyMed | date=2019-11-26 | url=https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2 | access-date=2020-04-23 | archive-date=2020-06-03 | archive-url=https://web.archive.org/web/20200603054800/https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0fd45bd-7d52-4fa6-a5f7-f46d5651ffa2 | dead-url=no }}</ref>
| class             = 
| ATCvet            = 
| ATC_prefix = J01
| ATC_suffix = DD08
| ATC_supplemental = 

<!-- Legal status -->
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_AU_comment = 
| legal_BR =  <!-- OTC, A1, A2, A3, B1, B2, C1, C2, C3, C4, C5, D1, D2, E, F-->
| legal_BR_comment = 
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_CA_comment = 
| legal_DE = <!-- Anlage I, II, III or Unscheduled-->
| legal_DE_comment = 
| legal_NZ = <!-- Class A, B, C -->
| legal_NZ_comment = 
| legal_UK = POM
| legal_UK_comment = <ref name="Suprax SmPC">{{cite web | title=Suprax 200 mg Tablets - Summary of Product Characteristics (SmPC) | website=(emc) | date=2019-08-20 | url=https://www.medicines.org.uk/emc/product/5534/smpc | access-date=2020-04-23 | archive-date=2020-07-27 | archive-url=https://web.archive.org/web/20200727191229/https://www.medicines.org.uk/emc/product/5534/smpc | dead-url=no }}</ref>
| legal_US = Rx-only
| legal_US_comment = 
| legal_UN = <!-- N I, II, III, IV / P I, II, III, IV-->
| legal_UN_comment = 
| legal_status = Rx-only

<!-- Pharmacokinetic data -->
| bioavailability = 30 to 50%<ref name=AHFS2016/>
| protein_bound = Approximately 60%
| metabolism = 
| metabolites       = 
| onset             = 
| elimination_half-life = 變化大<br />平均3-4小時
| duration_of_action = 
| excretion = [[腎臟|腎臟]]及膽道代謝

<!-- Identifiers -->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 79350-37-1
| CAS_supplemental  = 
| PubChem = 5362065
| IUPHAR_ligand     = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00671
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4514923
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = XZ7BG04GJX
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00258
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 472657
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1541
| NIAID_ChemDB      = 
| PDB_ligand        = 
| synonyms          = 

<!-- Chemical and physical data -->
| IUPAC_name = (6''R'',7''R'')-7-{[2-(2-Amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino}-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| C=16 | H=15 | N=5 | O=7 | S=2
| molecular_weight = 453.452 g/mol
| SMILES = O=C2N1/C(=C(/C=C)CS[C@@H]1[C@@H]2NC(=O)C(=N\OCC(=O)O)/c3nc(sc3)N)C(=O)O
| Jmol              = 
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H15N5O7S2/c1-2-6-4-29-14-10(13(25)21(14)11(6)15(26)27)19-12(24)9(20-28-3-8(22)23)7-5-30-16(17)18-7/h2,5,10,14H,1,3-4H2,(H2,17,18)(H,19,24)(H,22,23)(H,26,27)/b20-9-/t10-,14-/m1/s1
| StdInChI_comment  = 
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OKBVVJOGVLARMR-QSWIMTSFSA-N
| density           = 
| density_notes     = 
| melting_point     = 
| melting_high      = 
| melting_notes     = 
| boiling_point     = 
| boiling_notes     = 
| solubility        = 
| sol_units         = 
| specific_rotation = 
}}

<!-- Definition and medical uses -->
'''頭孢克肟'''（{{lang|en|Cefixime}}），是一種[[抗细菌藥|抗生素]]，用於治療多種[[病原细菌|细菌]]感染<ref name=AHFS2016/>，例如[[中耳炎|中耳炎]]、[[鏈球菌性咽炎|鏈球菌性咽炎]]、[[肺炎|肺炎]]、[[泌尿道感染|泌尿道感染]]、[[淋病|淋病]]和[[萊姆病|萊姆病]]<ref name=AHFS2016/>。治療淋病時通常只需口服一劑<ref name=WHO2008>{{cite book | title = WHO Model Formulary 2008 | year = 2009 | isbn = 9789241547659 | vauthors = ((World Health Organization)) | veditors = Stuart MC, Kouimtzi M, Hill SR | hdl = 10665/44053 | author-link = World Health Organization | page=107}}</ref>。在美國，本品是治療淋病的二線用藥<ref name=AHFS2016/>，一線用藥是[[頭孢曲松|頭孢曲松]]（{{lang-en|ceftriaxone}}）。本品的給藥方式為口服<ref name=AHFS2016/>。

<!-- Side effects and mechanism -->
常見的副作用為[[腹瀉|腹瀉]]、[[腹痛|腹痛]]和有[[噁心|噁心]]感<ref name=AHFS2016/>，可能的嚴重副作用則為出現[[過敏|過敏]]反應和引發[[偽膜性結腸炎|偽膜性結腸炎]]<ref name=AHFS2016/>。若患者曾有嚴重{{le|青黴素的副作用|Side effects of penicillin|青黴素過敏}}則不建議使用<ref name=WHO2008/>；但用於[[妊娠|懷孕]]患者應該是安全的<ref name="Drugs.com pregnancy" />。本品是[[頭孢菌素#第三代|第三代的頭孢菌素]]類藥物<ref name=AHFS2016/>，藥理機轉是藉由妨礙細菌的細胞壁生成，使細菌死亡<ref name=AHFS2016>{{cite web|title=Cefixime|url=https://www.drugs.com/monograph/cefixime.html|publisher=The American Society of Health—System Pharmacists|accessdate=2016-12-08|dead-url=no|archiveurl=https://web.archive.org/web/20161127220806/https://www.drugs.com/monograph/cefixime.html|archivedate=2016-11-27}}</ref>。

<!-- Society and culture -->
1979年，頭孢克肟取得專利，1989 年在[[美國|美國]]核可為醫藥用途<ref name=AHFS2016/><ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=495 |url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA495 |access-date=2020-06-01 |archive-date=2016-12-20 |archive-url=https://web.archive.org/web/20161220085422/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA495 |dead-url=no }}</ref>。本品名列[[世界卫生组织基本药物标准清单|世界衛生組織本藥物標準清單]]，認可為[[醫療系統|醫療系統]]中最安全有效的必需藥物之一<ref name="WHO21st">{{cite book | vauthors = ((World Health Organization)) | title = World Health Organization model list of essential medicines: 21st list 2019 | year = 2019 | hdl = 10665/325771 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO }}</ref>。在[[發展中國家|發展中國家]]，每劑批發價約在0.26到2.09美元之譜<ref name=ERC2014>{{cite web|title=Cefixime|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=1131&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=2016-12-08|archive-date=2018-01-22|archive-url=https://web.archive.org/web/20180122072946/http://mshpriceguide.org/en/single-drug-information/?DMFId=1131&searchYear=2014|dead-url=no}}</ref>，2015年，美國的整套療程所需劑量約要價100到200美元<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=86}}</ref>。
== 參考資料 ==
{{reflist}}


==外部連結==
* {{cite web | url = https://druginfo.nlm.nih.gov/drugportal/rn/79350-37-1 | publisher = U.S. National Library of Medicine | work = Drug Information Portal | title = Cefixime | accessdate = 2020-06-01 | archive-date = 2020-07-27 | archive-url = https://web.archive.org/web/20200727184449/https://druginfo.nlm.nih.gov/drugportal/rn/79350-37-1 | dead-url = no }}

{{细胞壁破坏性抗生素}}
{{portal bar|藥理學|醫學}}

[[Category:頭孢菌素|Category:頭孢菌素]]
[[Category:噻唑|Category:噻唑]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]